Pay in 4 interest-free payments of $6.00 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
The SUSTAIN-6 cardiovascular outcomes trial demonstrated that semaglutide reduced major adverse cardiovascular events by 26% in patients with type 2 diabetes and existing heart disease
Minimal Systemic Exposure Because of its short half-life and localized action, you dont get the widespread IGF-1 elevation that can cause issues with organ growth or insulin resistance seen with the systematic use of full-length IGF-1 for extended periods of time
Side effects at each dose Gastrointestinal side effects are common during titration
Made in a cGMP licensed facility, held to the highest standards
Alexander Shapsis , Board-Certified Gastroenterologist
Using the wrong syringe type will result in incorrect dosing
US$ 27.95
US$ 25.93
US$ 26.60
US$ 24.92
US$ 29.83
US$ 20.92
US$ 22.81
